NanoGroup S.A. (WSE:NNG)
Poland · Delayed Price · Currency is PLN 2.625
+0.015 (0.57%)
Feb 4, 2026, 5:00 PM CET
NanoGroup Revenue
NanoGroup had revenue of -6.90K PLN in the twelve months ending September 30, 2025. In the year 2024, NanoGroup had annual revenue of 2.10K with 4.01% growth.
Revenue (ttm)
-6.90K
Revenue Growth
+4.01%
P/S Ratio
-12,489.29
Revenue / Employee
n/a
Employees
n/a
Market Cap
86.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.10K | 81.00 | 4.01% |
| Dec 31, 2023 | 2.02K | -137.53K | -98.55% |
| Dec 31, 2022 | 139.55K | -352.94K | -71.66% |
| Dec 31, 2021 | 492.49K | -195.02K | -28.37% |
| Dec 31, 2020 | 687.51K | 169.78K | 32.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 29, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 295.81M |
| Ryvu Therapeutics | 90.41M |
| Synthaverse | 71.76M |
| Mabion | 14.81M |
| Captor Therapeutics Spolka Akcyjna | 7.57M |
| Molecure | 5.86M |
| Urteste | 1.80M |
| Pharmena | 1.27M |